News Image

Disc Medicine Reports Second Quarter 2025 Financial Results and Provides Business Update

Provided By GlobeNewswire

Last update: Aug 7, 2025

WATERTOWN, Mass., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, today reported financial results for the second quarter ended June 30, 2025, and provided a recap of recent program and corporate developments.

Read more at globenewswire.com

DISC MEDICINE INC

NASDAQ:IRON (10/8/2025, 8:00:02 PM)

After market: 70.28 0 (0%)

70.28

+2.39 (+3.52%)



Find more stocks in the Stock Screener

Follow ChartMill for more